Evolent Health, Inc.
HealthcareNYSE:EVH · New York Stock Exchange
+$0.22 today
Vol 2.11M · Avg 2.81M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-128.7%
avg -20.2%
ROIC
-0.3%
avg -8.2%
ROA
-28.1%
avg -6.3%
Analysis
ROIC is currently the strongest return metric at -0.3% versus its period average of -8.2%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Dan McCarthy | President | $1.16M | — | 41 | $423,022.00 | 0.38% |
Seth Barrie Blackley | Co-Founder, Chief Executive Officer & Director | $881,068.00 | — | 47 | $836,962.00 | 0.74% |
Emily Rafferty | Executive Vice President of Customer Success | $745,294.00 | — | 42 | $132,561.00 | 0.12% |
Jonathan David Weinberg | Chief Legal Officer, General Counsel & Secretary | $737,329.00 | — | 58 | $244,512.00 | 0.22% |
John Paul Johnson | Chief Strategy Officer | $555,639.00 | — | 42 | $309,245.00 | 0.27% |
Mario Marques Ramos | Chief Financial Officer | $513,333.00 | — | 54 | $429,041.00 | 0.38% |
Katie DiPerna Cook | Chief Operating Officer | $468,633.00 | — | — | — | — |
Aammaad Shams | Chief Accounting Officer | $341,783.00 | — | 42 | $66,847.00 | 0.06% |
Jessica White | Chief Information Officer | — | — | — | — | — |
John Tam | Chief Growth Officer | — | — | — | $309,245.00 | 0.27% |
Robert Cruz | Chief Technology Officer | — | — | — | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$38,199.00
Sells
0
$0.00
Net Sentiment
+$38,199.00
Net buying
Most Active
Springstubb Brendan B
1 transactions
Analysis
Insiders reported 1 buys worth $38,199.00 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $38,199.00. Springstubb Brendan B was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +114.7% | +22.7% (14yr)3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Recent growth has been strongest in Revenue at +114.7% over three years. Forward estimates point to Revenue at +22.7% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Butterfly Network, Inc.
NYSE:BFLY
$1.45B
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP
$1.42B
AMN Healthcare Services, Inc.
NYSE:AMN
$1.19B
MeiraGTx Holdings plc
NASDAQ:MGTX
$888.13M
Nutex Health, Inc.
NASDAQ:NUTX
$859.80M
Personalis, Inc.
NASDAQ:PSNL
$851.63M
Kura Oncology, Inc.
NASDAQ:KURA
$803.41M
HealthStream, Inc.
NASDAQ:HSTM
$763.39M
Replimune Group, Inc.
NASDAQ:REPL
$733.24M
Myriad Genetics, Inc.
NASDAQ:MYGN
$408.96M
Who manages EVH?
Evolent Health, Inc. (EVH) lists 11 active executives. The top listed executive is Jessica White, Chief Information Officer.
Are EVH insiders buying or selling?
Recent insider activity shows net selling of $40.26M.
Explore More
Continue the stock analysis
Jump to another research area for this company.